Porton announced the establishment of Porton U.S.A, LLC, a new subsidiary and Process Innovation Center located in Cranbury, New Jersey (NJ), United States. Deploying state-of-the-art laboratories and some of the industry’s most capable and experienced scientists, Porton’s New Jersey, Center will provide customers with impactful solutions to complex process challenges, next-generation process development, gram to kilogram cGMP syntheses of specialized pharmaceutical intermediates and APIs including highly potent APIs and antibody drug conjugates, etc. Through flexibly structured, yet close-knit collaborations and geographical proximity, Porton’s New Jersey, Center will bring new efficiencies to pharmaceutical development and lifecycle management for valued global customers.
